Biotech News 06 Oct 2025 How AI could speed the development of RNA vaccines and other RNA therapies MIT engineers used a machine-learning model to design nanoparticles that can deliver RNA to cells more efficiently. Using artificial intelligence,… Pantitra
Biotech News 23 Jul 2025 Tweak to mRNA Vaccine “Recipe” Improves Safety and Efficacy Tweaking the structure of the lipid nanoparticles that deliver mRNA reduces inflammation and boosts effectiveness. As millions of people know… Pantitra
Biotech News 11 Jun 2025 Rapid Biomimetic Nanovaccine for Personalized Cancer Therapy A recent article in Nature Communications describes a nanovaccine platform designed to support the development of personalized cancer vaccines. This approach uses… Pantitra
Biotech News 06 Jun 2025 New mRNA vaccine is more effective and less costly to develop, study finds A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1,… Pantitra
Biotech News 20 Feb 2025 Blood Test Predicts How Long Vaccines Will Protect You How long will vaccine protection last? A simple blood test may have the answer. Researchers at Stanford School of Medicine,… Pantitra
Biotech News 17 Feb 2025 Groundbreaking advances in tuberculosis vaccine development and therapies Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually. In a comprehensive review… Pantitra
Biotech News 11 Dec 2024 Needle-Free: New Nano-Vaccine Effective Against All COVID-19 Variants A new nano-vaccine developed by TAU and the University of Lisbon offers a needle-free, room-temperature-storable solution against COVID-19, targeting all key… Pantitra
Biotech News 27 Nov 2024 Innovating LNP design to improve mRNA therapeutics The new approach involving refinement and optimisation of ionisable lipids could accelerate the development of mRNA therapies, research suggests. A… Pantitra
Biotech News 28 Oct 2024 Novel mRNA vaccine prevents and treat C. difficile Penn Medicine and the Children’s Hospital of Philadelphia have developed the first mRNA vaccine against C. difficile to successfully ward… Pantitra
Biotech News 23 Sep 2024 Differentiating Between DNA and mRNA Platforms Ami Patel, PhD, provides insights on both technologies and how her research center, the Wistar Institute, is involved in DNA… Pantitra
